- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioInvent International AB (BINV)
BioInvent International AB stock price live, this page displays ST BINV stock exchange data. View the BINV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BioInvent International AB real time stock price chart below.
What Is the BioInvent International AB Stock Price Today?
The BioInvent International AB stock price today is 37.650.
What Is the Stock Symbol for BioInvent International AB?
The stock symbol for BioInvent International AB is ""BINV.""
What Stock Exchange Does BioInvent International AB Trade On?
BioInvent International AB is listed and trades on the Stockholm stock exchange.
Is BioInvent International AB a Good Stock to Buy?
Determining whether BioInvent International AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BINV quote. (ISIN: SE0015244520)
What Is the BioInvent International AB Stock Price Today?
The BioInvent International AB stock price today is 37.650.
What Is the Stock Symbol for BioInvent International AB?
The stock symbol for BioInvent International AB is ""BINV.""
What Stock Exchange Does BioInvent International AB Trade On?
BioInvent International AB is listed and trades on the Stockholm stock exchange.
Is BioInvent International AB a Good Stock to Buy?
Determining whether BioInvent International AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BINV quote. (ISIN: SE0015244520)
Stockholm
Currency in SEK
37.650
+0.600(+1.62%)
Closed·
Fair Value
An estimate of a BioInvent International's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.200
38.000
52 wk Range
22.700
50.800
BINV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BINV is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a BioInvent International's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.20038.000
52 wk Range
22.70050.800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BINV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a BioInvent International's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
92.500
Upside
+145.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell
BioInvent International AB Company Profile
BioInvent International AB (publ), a clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. The company’s drug candidates include BI-1808, an anti- tumor necrosis factor receptor-2 (TNFR2) antibody in Phase 2a trial for the treatment of solid tumors and a type of blood cancer; BI-1206, an anti-FcyRIIB antibody in Phase 1/2a trial for the treatment of non-Hodgkin’s lymphoma, as well as Phase 1/2a trial to treat advanced solid tumors; BI-1910, an anti-TNFR2 antibody in Phase 1/2a clinical trial to treat solid tumors; BI-1607, an anti-FcyRIIB antibody in Phase 1b/2a clinical trial to treat solid tumors; and BT-001, an anti- cytotoxic T lymphocyte-associated protein-4 (CTLA-4) antibody in Phase 1 clinical trial for the treatment of solid tumors. It has a partnership and collaboration with Transgene to develop BT-001 oncolytic viruses for treatment of solid tumors; collaboration and supply agreement with MSD to evaluate BI-1808, BI-1910, BI-1206, BI-1607, and BT-001 in combination with Keytruda; and licensing agreement with CASI Pharmaceuticals to develop BI-1206 in both hematological and solid cancers. BioInvent International AB (publ) was incorporated in 1996 and is based in Lund, Sweden.
Compare BINV to Peers and Sector
Metrics to compare | BINV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBINVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.3x | −9.6x | −0.5x | |
PEG Ratio | 0.13 | −0.20 | 0.00 | |
Price/Book | 3.2x | 6.6x | 2.6x | |
Price / LTM Sales | 40.7x | 42.2x | 3.3x | |
Upside (Analyst Target) | 145.7% | 12.5% | 42.8% | |
Fair Value Upside | Unlock | 8.2% | 6.5% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 92.500
(+145.68% Upside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
-1.77 / --
Revenue / Forecast
22.06M / --
FAQ
What Stock Exchange Does BioInvent International Trade On?
BioInvent International is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for BioInvent International?
The stock symbol for BioInvent International is "BINV."
What Is the BioInvent International Market Cap?
As of today, BioInvent International market cap is 2.48B.
What Is BioInvent International's Earnings Per Share (TTM)?
The BioInvent International EPS (TTM) is -7.12.
When Is the Next BioInvent International Earnings Date?
BioInvent International will release its next earnings report on 28 Oct 2025.
From a Technical Analysis Perspective, Is BINV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has BioInvent International Stock Split?
BioInvent International has split 8 times.
How Many Employees Does BioInvent International Have?
BioInvent International has 118 employees.
What is the current trading status of BioInvent International (BINV)?
As of 06 Aug 2025, BioInvent International (BINV) is trading at a price of 37.65, with a previous close of 37.65. The stock has fluctuated within a day range of 37.20 to 38.00, while its 52-week range spans from 22.70 to 50.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.